10.25.2023 OMA Board Book

Evidera provides evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products A metabolic therapeutics company focused on pioneering new approaches for the treatment of metabolic diseases, including type 2 diabetes and obesity. Their goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of T2D and obesity. Gan & Lee Pharmaceuticals is a leading pharmaceutical company in China specializing in the development, production, and commercialization of recombinant insulin analogs and injection pens,* with plans to expand globally. Kallyope, Inc. is a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis. Madrigal is a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases. Matinas Biopharma Holdings, Inc. is a biopharmaceutical company. The Company is focused on redefining the intracellular delivery of nucleic acids and small molecules through its lipid nanocrystal (LNC) drug delivery platform. Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Pfizer is a pharmaceuticals and biotechnology company. Regerenron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. We are a clinical-stage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other debilitating conditions. Selecta Biosciences is a clinical stage biotechnology company with a commitment to solving the challenges associated with autoimmunity and unwanted immunogenicity through our pioneering ImmTOR® precision immune tolerance platform. Shionogi Inc. is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs.

Biopharmaceutical, biotechnology

Pharmaceutical

Evidera

Received Grant

Biopharmaceutical, biotechnology

Received Grant

Fractyl

Biotechnology

Pharmaceutical

Received Grant

Pharmaceutical

Gan and Lee

Biotechnology

Received Grant

Biotechnology

Kallyope

Pharmaceutical

Madrigal

Biopharmaceutical

Received Grant

Biopharmaceutical

Received Grant

Pharmaceutical

Matinas

Pharmaceutical

Merck

Biotechnology, pharmaceutical

Received Grant

NewAmsterdam Pharma is a clinical stage company focused on the research and development of transformative therapies for cardio-metabolic diseases. Pharmaceutical Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. Pharmaceutical

Pharmaceutical

New Amsterdam

Received Grant

Pharmaceutical

Novartis

Received Grant

Pharmaceutical

NovoNordisk

Biotechnology, pharmaceutical

Received Grant

Pharmaceutical

Pfizer

Biotechnology, pharmaceutical

Received Grant

Pharmaceutical

Regerenron

Biotechnology

Received Grant

Pharmaceutical

Sanofi

Pharmaceutical

Received Grant

Pharmaceutical

Satsuma

Biopharmaceutical

Received Grant

Pharmaceutical

Selecta

Biotechnology

Received Grant

Pharmaceutical

Shionogi

Pharmaceutical company

Received Grant